Yves Dauvilliers

Istituto Giannina Gaslini — Italy

Neuroscience · Life Sciences

104h-index37.5kcitations1.1kworks3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sleep and Wakefulness Research(732), Sleep and related disorders(565), Restless Legs Syndrome Research(196), Circadian rhythm and melatonin(144), Parkinson's Disease Mechanisms and Treatments(133)

Publications1.1k total

Genetic Variants as a Potentially Arrhythmogenic Substrate in Mitral Annular Disjunction: Case Report and a Systematic Review of the Literature
Cardiogenetics·2026Open Access
Idiopathic hypersomnia is a 24-hour disorder
Journal of Clinical Sleep Medicine·2025· 1 citedOpen Access
Lack of association between G6PD variants and Parkinson disease
Human Genetics and Genomics Advances·2025Open Access
Effects of Oveporexton, an Orexin Receptor 2–Selective Agonist, on Cognition in Narcolepsy Type 1
JAMA Neurology·2025Open Access
Effects of low-sodium oxybate on diary-based sleep time in a clinical study in adults with idiopathic hypersomnia
Sleep Medicine·2025Open Access
Classification and clustering on nocturnal polysomnography: distinctions and overlaps between central disorders of hypersomnolence
SLEEP·2025· 1 citedOpen Access
The PREVCOG study: longitudinal and multimodal biomarker analyses for secondary prevention of Alzheimer's disease and cognitive decline in French memory clinics
Alzheimer s & Dementia·2025Open Access
Sleep time and SOREMPs features support idiopathic hypersomnia and narcolepsy type 2 as a single disease entity
SLEEP·2025
A new decision-making approach for residual excessive daytime sleepiness in individuals treated for obstructive sleep apnea–hypopnea syndrome: the blob-algorithm proposition
SLEEP·2025
Effects of High- Versus Low-Sodium Oxybate on Blood Pressure in Patients With Narcolepsy
Hypertension·2025Open Access
A Quest for a Histaminergic or Orexinergic Biomarker for Sudden Infant Death Syndrome
2025Open Access
OVEPOREXTON (TAK-861) FOR THE TREATMENT OF NARCOLEPSY TYPE 1: EFFICACY AND SAFETY RESULTS FROM TWO PIVOTAL PHASE 3 TRIALS
CHEST Journal·2025· 1 citedOpen Access
Underestimation of nocturnal sleep duration in central disorders of hypersomnolence: an underrecognized feature?
Journal of Clinical Sleep Medicine·2025
Genetics of Sleepwalking: Insights from whole exome sequencing
2025Open Access
Post-traumatic stress disorder and REM-sleep behavior disorder: exploring genetic associations and causal links
2025Open Access
Abstract FR498: Impact of Switching From High- to Low-Sodium Oxybate on Ambulatory and Office Blood Pressure in Subgroups of People With Narcolepsy From the XYLO Study
Hypertension·2025
<scp>SCORE2</scp> ‐Older Persons ( <scp>SCORE2</scp> ‐ <scp>OP</scp> ): Validation and Added Value of Excessive Daytime Sleepiness in a French Cohort
Journal of the American Geriatrics Society·2025Open Access
Once‐Nightly Sodium Oxybate Meets American Academy of Sleep Medicine Criteria for Treatment of Narcolepsy
Journal of Sleep Research·2025· 1 citedOpen Access
Lucid Dreaming: Not Just Awareness, but Agency
Journal of Sleep Research·2025Open Access
Age at Onset and Delays in Diagnosis of Central Disorders of Hypersomnolence Over the Past 30 Years
Journal of Sleep Research·2025· 1 citedOpen Access
page 1 of 53Next →

Frequent Co-authors

Isabelle Arnulf(15), Giuseppe Plazzi(14), Geert Mayer(14), Jacques Montplaisir(11), Claudio L. Bassetti(11), Karel Šonka(10), Gert Jan Lammers(10), Birgit Högl(9), Poul Jennum(9), Michel Lecendreux(9), Álex Iranzo(8), Mehdi Tafti(7), Emmanuel Mignot(7), Ronald B. Postuma(6), Joan Santamaría(6), Birgit Frauscher(6), Fabio Pizza(6), Michel Billiard(5), Markku Partinen(5), Sebastiaan Overeem(5)